公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis | Tan D.S.W.; Geater S.; CHONG-JEN YU ; Tsai C.-M.; Hsia T.-C.; Chen J.; Lin M.-C.; Lu Y.; Sriuranpong V.; Yang C.-T.; Sen P.; Branle F.; Shi M.; Wu Y.-L. | JTO Clinical and Research Reports | 5 | 0 | |
2008 | Characterization of the transcriptional regulation of the regulator of G protein signaling 2 (RGS2) gene during 3T3-L1 preadipocyte differentiation | Cheng Y.-S.; TZONG-SHYUAN LEE ; Hsu H.-C.; Yu R.K.; Wu Y.-L. | Journal of Cellular Biochemistry | 14 | 13 | |
2015 | Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6 | CHIH-HSIN YANG ; Sequist L.V.; Geater S.L.; Tsai C.-M.; Mok T.S.K.; Schuler M.; Yamamoto N.; CHONG-JEN YU ; Ou S.H.I.; Zhou C.; Massey D.; Zazulina V.; Wu Y.-L. | The Lancet Oncology | 766 | 644 | |
2021 | Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis | Kok P.-S.; Lee K.; Lord S.; CHIH-HSIN YANG ; Rosell R.; Goto K.; John T.; Wu Y.-L.; Mok T.S.K.; Lee C.K. | Lung Cancer | 4 | 4 | |
2001 | Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma | Lee Y.-L.; Ye Y.-L.; Yu C.-I.; Wu Y.-L.; Lai Y.-L.; Ku P.-H.; RUEY-LONG HONG ; BOR-LUEN CHIANG | Human Gene Therapy | 41 | 38 | |
2007 | CTGF enhances the motility of breast cancer cells via an integrin-αvβ3-ERK1/2-dependent S100A4-upregulated pathway | PO-HUANG LEE ; CHIUNG-NIEN CHEN ; KUO-TAI HUA ; Su J.-L.; Hong C.-C.; Chuang S.-E.; Chen M.-W.; Hua K.-T.; Wu Y.-L.; Cha S.-T.; Babu M.S.; KING-JEN CHANG ; Kuo M.-L. | Journal of Cell Science | 131 | 127 | |
2015 | Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy | Mok T.; Wu Y.-L.; Lee J.S.; CHONG-JEN YU ; Sriuranpong V.; Sandoval-Tan J.; Ladrera G.; Thongprasert S.; Srimuninnimit V.; Liao M.; Zhu Y.; Zhou C.; Fuerte F.; Margono B.; Wen W.; Tsai J.; Truman M.; Klughammer B.; Shames D.S.; Wu L. | Clinical Cancer Research | 408 | 382 | |
2016 | Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: Post hoc analyses of the randomized LUX-Lung 3 and 6 trials | CHIH-HSIN YANG ; Sequist L.V; Zhou C; Schuler M; Geater S.L; Mok T; Hu C.-P; Yamamoto N; Feng J; O'Byrne K; Lu S; Hirsh V; Huang Y; Sebastian M; Okamoto I; Dickgreber N; Shah R; Märten A; Massey D; Wind S; Wu Y.-L. | Annals of Oncology | 150 | 142 | |
2010 | EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: Role of haem oxygenase-1 | Tsai J.-Y.; Su K.-H.; Shyue S.-K.; Kou Y.R.; Yu Y.-B.; Hsiao S.-H.; Chiang A.-N.; Wu Y.-L.; Ching L.-C.; TZONG-SHYUAN LEE | Cardiovascular Research | 70 | 67 | |
2021 | Evaluation of using satellite-derived aerosol optical depth in land use regression models for fine particulate matter and its elemental composition | Huang C.-S.; Liao H.-T.; Lin T.-H.; JUNG-CHI CHANG ; Lee C.-L.; Yip E.C.-W.; Wu Y.-L.; CHANG-FU WU | Atmosphere | 1 | 1 | |
2008 | Exacerbation of wood smoke-induced acute lung injury by mechanical ventilation using moderately high tidal volume in mice | Yang Y.-L.; Tang G.-J.; Wu Y.-L.; Yien H.-W.; TZONG-SHYUAN LEE ; Kou Y.R. | Respiratory Physiology and Neurobiology | 13 | 12 | |
2017 | First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study | Soria J.-C.; Tan D.S.W.; Chiari R.; Wu Y.-L.; Paz-Ares L.; Wolf J.; Geater S.L.; Orlov S.; Cortinovis D.; CHONG-JEN YU ; Hochmair M.; Cortot A.B.; Tsai C.-M.; Moro-Sibilot D.; Campelo R.G.; McCulloch T.; Sen P.; Dugan M.; Pantano S.; Branle F.; Massacesi C.; de Castro G.; Jr | The Lancet | 901 | 771 | |
2017 | Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival | Lee C.K.; Davies L.; Wu Y.-L.; Mitsudomi T.; Inoue A.; Rosell R.; Zhou C.; Nakagawa K.; Thongprasert S.; Fukuoka M.; Lord S.; Marschner I.; YU-KANG TU ; Gralla R.J.; Gebski V.; Mok T.; CHIH-HSIN YANG | Journal of the National Cancer Institute | 201 | 171 | |
2015 | Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia | Machiela M.J.; Hsiung C.-A.; Shu X.-O.; Seow W.J.; Wang Z.; Matsuo K.; Hong Y.-C.; Seow A.; Wu C.; Hosgood H.D.; III, Chen K.; Wu J.; Lim W.-Y.; Chen K.-C.; Chow W.-H.; Ji B.-T.; Chan J.K.C.; Chu M.; Li Y.-J.; Yokota J.; Li J.; Wang J.-C.; Chen H.; Xiang Y.-B.; CHONG-JEN YU ; Kunitoh H.; Wu G.; Jin L.; Lo Y.-L.; Shiraishi K.; Chen Y.-H.; Lin H.-C.; Wen W.; Wu T.; Wong M.P.; Wu Y.-L.; PAN-CHYR YANG ; Zhou B.; Shin M.-H.; Fraumeni J.F.; Jr.; Zheng W.; Lin D.; Cawthon R.; Chanock S.J.; Rothman N.; Lan Q.; Chatterjee N.; Hu W.; Caporaso N.E.; Park J.Y.; Chen C.-J.; Kim Y.H.; Kim Y.T.; Landi M.T.; Shen H.; Lawrence C.; Burdett L.; Yeager M.; Chang I.-S.; Mitsudomi T.; Kim H.N.; Chang G.-C.; Bassig B.A.; Tucker M.; Wei F.; Yin Z.; An S.-J.; Qian B.; Lee V.H.F.; Lu D.; Liu J.; Jeon H.-S.; Hsiao C.-F.; Sung J.S.; Kim J.H.; Gao Y.-T.; Tsai Y.-H.; Jung Y.J.; Guo H.; Hu Z.; Hutchinson A.; Wang W.-C.; Klein R.J.; Chung C.C.; Oh I.-J.; KUAN-YU CHEN ; Berndt S.I.; Wu W.; Chang J.; Zhang X.-C.; Huang M.-S.; Zheng H.; Wang J.; Zhao X.; Li Y.; Choi J.E.; Su W.-C.; Park K.H.; Sung S.W.; Chen Y.-M.; Liu L.; Kang C.H.; Hu L.; Chen C.-H.; Pao W.; Kim Y.-C.; Yang T.-Y.; Xu J.; Guan P.; Tan W.; Su J.; Wang C.-L.; Li H.; Sihoe A.D.L.; Zhao Z.; Chen Y.; Choi Y.Y.; Hung J.-Y.; Kim J.S.; Yoon H.-I.; Cai Q.; Lin C.-C.; Park I.K.; Xu P.; Dong J.; Kim C.; He Q.; Perng R.-P.; Kohno T.; Kweon S.-S.; Chen C.-Y.; Vermeulen R.C.H. | International Journal of Cancer | 79 | 67 | |
2012 | Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia | Lan Q.; Hsiung C.-A.; Matsuo K.; Hong Y.-C.; Seow A.; Wang Z.; Hosgood H.D.; Chen K.; Wang J.-C.; Chatterjee N.; Hu W.; Chen C.-Y.; Vermeulen R.; Wu J.; Lim W.-Y.; Chen K.-C.; Chow W.-H.; Ji B.-T.; Chan J.K.C.; Chu M.; Li Y.-J.; Wong M.P.; Yokota J.; Li J.; Chen H.; Xiang Y.-B.; CHONG-JEN YU ; Kunitoh H.; Wu G.; Jin L.; Lo Y.-L.; Shiraishi K.; Zheng W.; Chen Y.-H.; Lin H.-C.; Wu T.; Wu Y.-L.; PAN-CHYR YANG ; Zhou B.; Shin M.-H.; Fraumeni J.F.; Lin D.; Chanock S.J.; Caporaso N.; Rothman N.; Park J.Y.; Chen C.-J.; Kim Y.H.; Kim Y.T.; Landi M.T.; Shen H.; Lawrence C.; Burdett L.; Yeager M.; Yuenger J.; Jacobs K.B.; Chang I.-S.; Mitsudomi T.; Kim H.N.; Chang G.-C.; Bassig B.A.; Tucker M.; Wei F.; Yin Z.; Wu C.; An S.-J.; Qian B.; Lee V.H.F.; Lu D.; Liu J.; Jeon H.-S.; Hsiao C.-F.; Sung J.S.; Kim J.H.; Gao Y.-T.; Tsai Y.-H.; Jung Y.J.; Guo H.; Hu Z.; Hutchinson A.; Wang W.-C.; Klein R.; Chung C.C.; Oh I.-J.; KUAN-YU CHEN ; Berndt S.I.; He X.; Wu W.; Chang J.; Zhang X.-C.; Huang M.-S.; Zheng H.; Wang J.; Zhao X.; Li Y.; Choi J.E.; Su W.-C.; Park K.H.; Sung S.W.; Shu X.-O.; Chen Y.-M.; Liu L.; Kang C.H.; Hu L.; Chen C.-H.; Pao W.; Kim Y.-C.; Yang T.-Y.; Xu J.; Guan P.; Tan W.; Su J.; Wang C.-L.; Li H.; Sihoe A.D.L.; Zhao Z.; Chen Y.; Choi Y.Y.; Hung J.-Y.; Kim J.S.; Yoon H.-I.; Cai Q.; Lin C.-C.; Park I.K.; Xu P.; Dong J.; Kim C.; He Q.; Perng R.-P.; Kohno T.; Kweon S.-S. | Nature Genetics | 260 | 245 | |
2009 | Ginkgo biloba extract confers protection from cigarette smoke extract-induced apoptosis in human lung endothelial cells: Role of heme oxygenase-1 | Hsu C.-L.; Wu Y.-L.; Tang G.-J.; TZONG-SHYUAN LEE ; Kou Y.R. | Pulmonary Pharmacology and Therapeutics | 53 | 49 | |
2014 | Glucosamine attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling | Wu Y.-L.; Lin A.-H.; Chen C.-H.; Huang W.-C.; Wang H.-Y.; Liu M.-H.; TZONG-SHYUAN LEE ; Ru Kou Y. | Free Radical Biology and Medicine | 47 | 44 | |
2009 | Glucosamine inhibits IL-1β-mediated IL-8 production in prostate cancer cells by MAPK attenuation | Tsai C.-Y.; TZONG-SHYUAN LEE ; Kou Y.R.; Wu Y.-L. | Journal of Cellular Biochemistry | 28 | 29 | |
2010 | Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells | Wu Y.-L.; Kou Y.R.; Ou H.-L.; Chien H.-Y.; Chuang K.-H.; Liu H.-H.; TZONG-SHYUAN LEE ; Tsai C.-Y.; Lu M.-L. | European Journal of Pharmacology | 24 | 23 | |
2022 | Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial | Majem M.; Goldman J.W.; John T.; Grohe C.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.V.; Lu S.; Li S.; Lee K.Y.; Akewanlop C.; CHONG-JEN YU ; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Atagi S.; Zeng L.; Kulkarni D.; Medic N.; Tsuboi M.; Herbst R.S.; Wu Y.-L. | Clinical Cancer Research | 11 | 9 |